• Publications
  • Influence
Drug-eluting bioabsorbable stents - an in vitro study.
The aim of this study was to investigate the drug elution properties of novel drug-eluting bioabsorbable stents in vitro with four different drugs: dexamethasone, indomethacin, simvastatin andExpand
  • 28
  • 1
Urethral in situ biocompatibility of new drug‐eluting biodegradable stents: an experimental study in the rabbit
To assess the effect of drug‐eluting properties on the degradation process and the biocompatibility of biodegradable drug‐eluting urethral stents.
  • 14
  • 1
Biodegradable braided poly(lactic‐co‐glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study
To evaluate, in a pilot study, the efficacy and safety of combining a braided poly(lactic‐co‐glycolic acid) (PLGA, a copolymer of l‐lactide and glycolide) urethral stent and dutasteride in theExpand
  • 16
  • 1
  • PDF
Tissue biocompatibility of new biodegradable drug-eluting stent materials
Drug-eluting stents are a recent innovation for endovascular and endourethral purposes. The aim of this study was to assess the biocompatibility of new biodegradable drug-eluting stent materials inExpand
  • 24
Biocompatibility of new drug-eluting biodegradable urethral stent materials.
OBJECTIVES To investigate the effects of biodegradable stent material (poly-96L/4D-lactic acid [PLA]) on the production of cytokines and other inflammatory mediators in vitro and the biocompatibilityExpand
  • 15
Preclinical evaluation of new indomethacin-eluting biodegradable urethral stent.
PURPOSE To evaluate the effect of an indomethacin-eluting biodegradable urethral stent on the production of inflammatory cytokines in vitro and the degradation and biocompatibility of the new stentExpand
  • 11
A new biodegradable braided self-expandable PLGA prostatic stent: an experimental study in the rabbit.
PURPOSE The biodegradable PLGA (a copolymer of L-lactide and glycolide) urethral stent with a spiral configuration has been used clinically for the prevention of postoperative urinary retention afterExpand
  • 14
Dexamethasone-eluting vascular stents.
Percutaneous transluminal angioplasty (PTA) with stenting is widely used in the treatment of vascular disorders, but restenosis remains a significant problem. Drug-eluting stents (DES) have beenExpand
  • 10
The effect of pH on the degradation of biodegradable poly(L-lactide-co-glycolide) 80/20 urethral stent material in vitro.
PURPOSE To investigate in vitro whether pH ranging between 6 and 9 has an effect on the degradation of stent fibers made of poly(l-lactide-co-glycolide) (PLGA) 80/20. MATERIALS AND METHODS TheExpand
  • 6
Muraglitazar-eluting bioabsorbable vascular stent inhibits neointimal hyperplasia in porcine iliac arteries.
PURPOSE To evaluate the biocompatibility of a new muraglitazar-eluting polylactide copolymer stent and investigate its ability to prevent the formation of intimal hyperplasia. MATERIALS AND METHODSExpand
  • 5